ASP015K
Drug timelines are a Plus or Pro feature.
29 regulatory and trial events tracked for ASP015K, covering 2010-08-16 to 2025-05-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate [Phase 2]